QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-reiterates-market-perform-on-apyx-medical

JMP Securities analyst David Turkaly reiterates Apyx Medical (NASDAQ:APYX) with a Market Perform.

 apyx-medical-announces-peer-reviewed-clinical-publication-comparing-the-use-of-renuvion-to-a-competing-technology-following-liposuction-or-body-contouring-procedures

Demonstrates a statistically significant reduction in adverse events associated with the use of Renuvion following liposuction ...

 apyx-medical-q2-gaap-eps-019-beats-020-estimate-sales-1215m-beat-1175m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) ...

 apyx-medicals-new-renewing-lives-campaign-offers-free-renuvion-treatments-to-those-in-need

Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary heli...

 apyx-medical-q1-eps-022-misses-020-estimate-sales-1024m-beat-953m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.21...

 crude-oil-moves-lower-accenture-shares-tumble-after-q2-results

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow t...

 why-factset-research-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...

 gold-gains-1-micron-posts-upbeat-results

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow tra...

 apyx-medical-expects-fy2024-sales-of-497m-529m-versus-consensus-of-6018m-with-net-loss-of-265m-243m

Total revenue guidance assumes: Advanced Energy revenue in the range of $41.6 million to $44.6 million, representing a de...

 apyx-medical-q4-gaap-eps-028-may-not-be-comparable-to-018-estimate-sales-1466m-miss-1485m-estimate

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.18...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION